...to AureoGen Biosciences Inc.’s preclinical aureobasidin A derivatives to treat infectious disease, and partnered with OpGen Inc....
...Services (CMS), Baltimore, Md. Harvard University, Cambridge, Mass. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. OpGen Inc....

...3/28/19 $345.0 $3,608.4 $4,608.4 28% Moleculin Biotech Inc. (NASDAQ:MBRX) (A) 3/28/19 $5.3 NA $56.5 NA OpGen Inc....

...Infectious disease and diagnostic company OpGen Inc. (NASDAQ:OPGN) raised $12 million through the sale of 2.8 million...
...exercise price of $3.25. H.C. Wainwright acted as the placement agent. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Alicia Parker OpGen Inc....

...On July 13, infectious disease and diagnostic company OpGen Inc. (NASDAQ:OPGN) raised $10 million through the sale...
...share and a five-year warrant to purchase a share at $0.43. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Alicia Parker OpGen Inc....

...and diagnostic company OpGen Inc. (NASDAQ:OPGN) proposed to raise up to $10 million in a follow-on. OpGen Inc....
...NASDAQ:OPGN) proposed to raise up to $10 million in a follow-on. OpGen Inc. (NASDAQ:OPGN), Gaithersburg, Md. Julian Zhu OpGen Inc....

...to detect antimicrobial resistance. Merck will provide OpGen access to its bacterial pathogens archive, and OpGen...
...pharma will have access to OpGen's Lighthouse portal. The companies declined to provide financial terms. OpGen Inc....
...NASDAQ:OPGN), Gaithersburg, Md. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Business: Diagnostic Shannon Lehnbeuter Merck & Co. Inc. OpGen Inc....

...5/6/15 $55.0 $151.4 $134.7 -11% HTG Molecular Diagnostics Inc. (NASDAQ:HTGM) 5/6/15 $50.0 $94.3 $76.1 -19% OpGen Inc....

...immunotherapy company Adaptimmune Therapeutics plc (NASDAQ:ADAP), migraine treatment developer CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD), diagnostics company OpGen Inc....
...COL-144 ), its oral selective agonist of serotonin (5-HT1F) receptor, to treat acute migraine. OpGen...
...share and a five-year warrant to purchase another share at $6.60. The offering price valued OpGen...